Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Stock-based Compensation Expense

The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):

	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cost of revenue	$	4,329	$	2,835	$	12,570	$	7,082
Research and development	15,634		13,996		45,876		37,954
Sales and marketing	14,085		12,166		40,362		28,977
General and administrative	20,865		16,690		65,560		44,305
Restructuring	—		—		(1,060)		—
Total	$	54,913	$	45,687	$	163,308	$	118,318

Schedule of Nonvested Restricted Stock Shares Activity

A summary of our restricted stock unit (RSU) activity is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2023	14,409,166	$	27.37
Granted	19,229,577	16.32
Released	(4,090,297)	26.77
Forfeited	(2,516,121)	22.28
Outstanding as of October 31, 2023	27,032,325	$	19.86

Schedule of Share-based Payment Arrangement, Option, Activity

A summary of our stock option activity is as follows:

	Number of Options	Weighted-Average Exercise Price
Outstanding as of January 31, 2023	32,446,814	$	4.71
Exercised	(6,484,688)	$	2.68
Forfeited	(583,334)	$	5.54
Outstanding as of October 31, 2023	25,378,792	$	5.22
Expected to vest as of October 31, 2023	25,378,792	$	5.22
Vested and exercisable as of October 31, 2023	18,189,967	$	4.10